Related Experiment Video
Updated: May 22, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes
Li Tian1, Shiyin Long, Chuanwei Li
1Laboratory of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China.
Insights
Diabetic patients with coronary heart disease (CHD) show abnormal high-density lipoprotein (HDL) subclasses and particle sizes, increasing cardiovascular risk. HDL subclass distribution may aid in stratifying CHD severity and risk, especially with controlled lipid levels.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Lipidology
Background:
- Coronary heart disease (CHD) prevalence is higher in individuals with diabetes.
- Investigated high-density lipoprotein (HDL) subclass profiles and particle size alterations in CHD patients with and without diabetes.
Purpose of the Study:
- To investigate HDL subclass profiles and particle size alterations in CHD patients with and without diabetes.
Main Methods:
- Quantified plasma HDL subclasses in CHD patients using 1-dimensional gel electrophoresis coupled with immunodetection.
Main Results:
- CHD patients with diabetes had higher fasting plasma glucose, triglyceride, total cholesterol, LDL-C, and HDL₃ subclasses, but lower HDL-C, HDL(2b+preβ2), and HDL(2a) compared to those without diabetes.
- Gensini Score was independently predicted by HDL(2a) and HDL(2b+preβ2) subclasses.
- Despite statin therapy, HDL particle size tended to be smaller in CHD patients.
Conclusions:
- Abnormal HDL subpopulations distribution and particle size may contribute to CHD risk in diabetic patients.
- HDL subclass distribution can aid in assessing coronary artery severity and risk stratification, particularly in CHD patients with managed lipid profiles.
Background:
A higher prevalence of coronary heart disease (CHD) in people with diabetes. We investigated the high-density lipoprotein (HDL) subclass profiles and alterations of particle size in CHD patients with diabetes or without diabetes.
Methods:
Plasma HDL subclasses were quantified in CHD by 1-dimensional gel electrophoresis coupled with immunodetection.
Results:
Although the particle size of HDL tend to small, the mean levels of low density lipoprotein cholesterol(LDL-C) and total cholesterol (TC) have achieved normal or desirable for CHD patients with or without diabetes who administered statins therapy. Fasting plasma glucose (FPG), triglyceride (TG), TC, LDL-C concentrations, and HDL₃ (HDL(3b) and (3a)) contents along with Gensini Score were significantly higher; but those of HDL-C, HDL(2b+preβ2), and HDL(2a) were significantly lower in CHD patients with diabetes versus CHD patients without diabetes; The preβ₁-HDL contents did not differ significantly between these groups. Multivariate regression analysis revealed that Gensini Score was significantly and independently predicted by HDL(2a), and HDL(2b+preβ2).
Conclusions:
The abnormality of HDL subpopulations distribution and particle size may contribute to CHD risk in diabetes patients. The HDL subclasses distribution may help in severity of coronary artery and risk stratification, especially in CHD patients with therapeutic LDL, TG and HDL levels.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management
Atherosclerosis I: Introduction
